Adjuvant Global Health Technology Fund, L.P.

Holdings History for AN2 Therapeutics, Inc. - Common Stock, par value $0.00001 per share (ANTX)

Symbol: ANTX on Nasdaq
Investment type: Equity / Common Stock, par value $0.00001 per share
Latest Disclosed Shares Owned: 2,373,500 shares
Security Ownership %: 7.9%

Adjuvant Capital GP, L.P. ownership in AN2 Therapeutics, Inc. Common Stock, par value $0.00001 per share (ANTX)

28 Feb 2025 - Adjuvant Capital GP, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2,373,500 shares of AN2 Therapeutics, Inc. Common Stock, par value $0.00001 per share (ANTX). This represents 7.9% ownership of the company. This is the first filing by Adjuvant Global Health Technology Fund, L.P. disclosing ownership of AN2 Therapeutics, Inc. Common Stock, par value $0.00001 per share (ANTX).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Adjuvant Capital GP, L.P.	7.9%		$3,061,815	2,373,500			$1.29	13G/A	31 Dec 2024	28 Feb 2025, 19:57